doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
Safety comes first
Cyanocobalamin is distributed into breast milk in amounts similar to those in maternal plasma, and distribution in breast milk allows for adequate intakes of cyanocobalamin by breast-feeding infants
A: Minimum 98% purity confirmed by HPLC, with LC-MS molecular identity confirmation (C78H123N23O23S2, ~1,817 Da)
Achieving the best results isnt just about the treatment itself
While Semaglutide GLP-1s weight-reducing effects are promising, its crucial to remember that it may also have side effects, such as nausea, diarrhea, and constipation
